Close

Abbott Laboratories (ABT) to Acquire CFR Pharma in ~$3.3B Deal

May 16, 2014 7:32 AM EDT Send to a Friend
Abbott Laboratories (NYSE: ABT) announced a definitive agreement to acquire Latin American pharmaceutical company CFR Pharmaceuticals, more than doubling its ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login